Indian Hospital Chain Apollo Partners With Zebra Medical to Fight Tuberculosis
The $4.9 million partnership will focus on the development of an AI-based chest X-ray interpretation tool for the early detection of tuberculosis
Medical analytics company Zebra Medical Vision Ltd. and HealthNet Global Ltd., a subsidiary of Indian hospital chain Apollo Hospitals Enterprise Ltd., have partnered to advance the early detection of tuberculosis in hospitals throughout India, the two companies announced Wednesday.
The $4.9 million partnership will focus on the development of an AI-based chest X-ray interpretation tool capable of detecting early signs of tuberculosis, according to the companies’ statement.
Zebra Medical Co-Founder Eyal Gura. Photo: Zvika Tishler
The Apollo Hospitals Group maintains 10,164 beds across more than 70 hospitals and owns 3,272 pharmacies, according to company statements.
Founded in 2014 and based in Shefayim, a kibbutz in central Israel, Zebra Medical uses machine learning algorithms for the automated analysis of radiological scans such as X-ray and MRI. Its technology can detect various medical conditions, including liver diseases, lung conditions, and cardiovascular issues.
Zebra Medical has been offering its algorithm bundle to health providers at $1 per scan, since 2017.
In June, the company announced a $30 million funding round, bringing its total funding raised to date to $50 million, according to Pitchbook data.